VNRX SEC Filings: 8-K, 10-Q, S-3 & 424B – VolitionRX

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 13, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 14, 2026

10-K/A

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Apr 30, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 31, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 13, 2025

10-Q/A

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

Aug 15, 2025

News

TYPE

HEADLINE

FILED AT

8-K

VolitionRx Announces $500,000 Partial Pre-Payment of Convertible Note and Debt Reduction Agreement

Oct 27, 2026

8-K

VolitionRx Issues Common Stock to Satisfy Note Conversion Obligations

Sep 25, 2026

8-K

VolitionRx Issues Common Stock to Satisfy Note Conversion Obligations

Sep 15, 2026

8-K

VolitionRx Announces Full Pre-Payment of $7.5 Million Senior Secured Convertible Promissory Note

Sep 14, 2026

8-K

VolitionRx Limited Enters into Waiver and Consent Agreement with Lind Global Asset Management XII LLC

Sep 2, 2026

8-K

VolitionRx Limited Issues Common Stock to Satisfy Convertible Note Obligations

Sep 1, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

REGISTERED OFFERING

Jun 9, 2026

424B5

PENDING FIXED PRICE OFFERING | Bank: Maxim Group LLC

Jun 5, 2026

424B5

Oct 14, 2025

424B5

PENDING FIXED PRICE OFFERING | Bank: Newbridge Securities Corporation

Oct 9, 2025

424B5

August 2025 ATM | Amount sold to date: $527,141 | Float: 95,933,385

Aug 14, 2025

424B5

REGISTERED OFFERING

Aug 4, 2025

Registrations

TYPE

HEADLINE

FILED AT

S-3/A

SHARE RESALE REGISTRATION

Sep 8, 2026

S-3/A

SHARE RESALE REGISTRATION

Sep 8, 2026

S-3

SHARE RESALE REGISTRATION

Aug 28, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Aug 21, 2026

S-3

SHARE RESALE REGISTRATION

Jul 10, 2026

S-3

SHARE RESALE REGISTRATION

Feb 9, 2026

Proxies

TYPE

HEADLINE

FILED AT

DEF 14A

Form DEF 14A - Other definitive proxy statements

Jun 2, 2026

PRE 14A

Form PRE 14A - Other preliminary proxy statements

May 13, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Feb 11, 2026

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Jan 26, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 29, 2025

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Apr 4, 2025

Ownerships

TYPE

HEADLINE

FILED AT

Batchelor Ann-Louise (Reporting)

Oct 23, 2026

Forterre Gael (Reporting)

Sep 30, 2026

Michel Gaetan (Reporting)

Sep 30, 2026

SCHEDULE 13D/A

Lagoda Investment Management, L.P. (Filed by)

Sep 16, 2026

S-3/A

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

Sep 8, 2026

S-3/A

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

Sep 8, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Sep 11, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Jul 20, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Feb 20, 2026

CORRESP

Form CORRESP - Correspondence

Feb 17, 2026

LETTER

Form UPLOAD - SEC-generated letter

Feb 13, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Jul 15, 2025

VolitionRX Ltd VNRX · SEC Filings